Dexcom Stelo Review: The First CGM Designed for Non-Diabetics

The CGM Revolution Reaches Healthy Adults#

Continuous glucose monitors have existed since the early 2000s, but they required a prescription and were designed exclusively for diabetics. In 2024, that changed. The FDA cleared the Dexcom Stelo — the first CGM specifically designed and approved for use by non-diabetic, healthy adults.

As a physician with a focus on preventive medicine and longevity, I have been prescribing CGMs off-label to healthy patients for years. The Stelo makes this accessible to everyone.

I wore three consecutive 14-day Stelo sensors — 42 days of continuous glucose data — while systematically testing food responses, exercise effects, sleep correlations, and stress impact. This is what I found.

---

Why Glucose Matters for Longevity#

Blood glucose is not just a diabetic concern. Chronic glucose dysregulation — even within "normal" fasting ranges — is one of the most powerful drivers of accelerated biological aging.

What glucose dysregulation does:

• Glycation: Elevated glucose glycates (attaches to) proteins, producing AGEs (advanced glycation end-products) that stiffen arteries, accelerate skin aging, and damage neuronal function
• Insulin resistance: Chronic glucose elevation drives compensatory insulin secretion, eventually leading to insulin resistance — a precursor to type 2 diabetes, NAFLD, and Alzheimer's disease
• Inflammation: Glucose spikes activate NF-κB inflammatory pathways
• Mitochondrial dysfunction: Chronic glucose excess generates excess ROS, impairing mitochondrial function

The EPIC-Norfolk study found that each 1% increase in HbA1c above 5% was associated with a significant increase in all-cause mortality — even in people without diabetes.

---

The Dexcom Stelo: What It Is#

The Stelo is a small (3cm oval) sensor worn on the back of the upper arm. A thin flexible filament (0.4mm diameter) penetrates just below the skin surface, measuring interstitial fluid glucose every 5 minutes. Data is transmitted via Bluetooth to the Dexcom app on your phone.

Key specs:

• Sensor life: 15 days (the app says 15; real-world experience is 14–15)
• Accuracy: MARD of 7.8% (mean absolute relative difference vs. fingerstick reference)
• Range: 55–250 mg/dL display
• Warm-up: 2 hours after sensor insertion
• Waterproof: IP27 (swimming and bathing safe)
• No calibration required (though fingerstick option available)

Application: The applicator makes sensor insertion painless — a brief click and the sensor is in place. I experienced mild itching for the first 4–6 hours with each sensor, which resolved completely.

---

Accuracy: How Does It Compare?#

In medical-grade validation studies, the Stelo achieved a MARD of 7.8%. In practical terms, if your true glucose is 100 mg/dL, the Stelo reads between 92–108 mg/dL approximately 68% of the time (within 1 standard deviation).

This is sufficient for:

• Identifying glucose trends and patterns
• Comparing relative responses to different foods
• Tracking time-in-range improvements
• Early detection of metabolic dysfunction patterns

It is NOT sufficient for:

• Dosing insulin (not the intended use)
• Replacing fingerstick for clinical decisions

For healthy adults using CGM for metabolic optimisation, this accuracy is entirely adequate.

---

What I Discovered Wearing It for 42 Days#

Discovery 1: Sleep is the most important glucose intervention#

The most striking pattern across 42 days was the relationship between sleep quality and next-day glucose. Nights with fewer than 6.5 hours of sleep consistently produced:

• Fasting glucose 8–12 mg/dL higher the following morning
• Post-meal peaks 20–35% higher than equivalent meals on well-slept days
• Time-in-range dropping from above 90% to 78–82%

This data made the sleep-metabolic health connection viscerally real in a way that reading studies could not. After observing my own glucose dysregulate following poor sleep four times in six weeks, I restructured my entire evening routine.

Discovery 2: Meal order matters more than meal content#

Testing the same meal (brown rice, chicken, broccoli) in different eating orders:

• Carbs first: Peak glucose 147 mg/dL
• Protein + vegetables first, carbs last: Peak glucose 118 mg/dL
• 10-minute walk after meal: Peak reduced by additional 14 mg/dL

Eating order and post-meal movement — both zero-cost, zero-calorie interventions — reduced peak glucose by 29% in our testing.

Discovery 3: Stress raises glucose independently of food#

On three high-stress days (two involving presentations, one involving a difficult professional situation), I observed glucose rising 15–25 mg/dL during the stressful period with no food intake. This is cortisol-mediated hepatic glucose output — the liver releases stored glycogen in response to stress hormones.

The Stelo made stress-mediated glucose elevations undeniable. Two weeks of data showing glucose spikes during Monday morning meetings convinced me to adopt box breathing before presentations.

Discovery 4: Individual variation in food responses is enormous#

The most personalised finding: my glucose response to oat porridge (a supposedly "healthy" breakfast) was consistently higher than to 2 eggs with avocado — peaking at 138 mg/dL vs. 84 mg/dL for the same caloric load. This cannot be predicted from glycaemic index tables. CGM makes it personal.

Discovery 5: Exercise timing matters#

Cardio before breakfast (fasted): Glucose dropped from ~90 to 72 mg/dL during the session, then rebounded to 88 as liver glycogenolysis compensated. Post-workout glucose remained lower for 4–6 hours.

Strength training (fasted): Initial glucose spike to 108 mg/dL (liver glucose dump from exercise-induced adrenaline), then progressive decline over 2 hours.

Post-meal walk (15 minutes): Consistently the single most effective glucose management tool — blunted post-meal peaks by 15–25 mg/dL in every test.

---

The App: Dexcom's Competitive Advantage#

The Dexcom app is the cleanest CGM interface available. Key features:

Urgency Low alerts: Even in non-diabetic mode, the Stelo alerts at below 70 mg/dL — important for identifying reactive hypoglycaemia after high-carbohydrate meals.

Pattern recognition: The app identifies recurring patterns — morning glucose trends, post-meal response patterns, overnight behaviour. These summaries are generated automatically and are genuinely insightful.

Daily stats: Time in Range, Average Glucose, and Glucose Variability (coefficient of variation %) are shown clearly. Variability CV% is particularly important — a CV above 36% indicates metabolic instability even if average glucose appears normal.

Activity correlation: Syncs with Apple Health and Google Fit to overlay physical activity on your glucose graph.

---

Cost Analysis: Is $99/Month Worth It?#

At $99/month ($1,188/year), the Stelo is a significant commitment. Our recommendation:

Wear it for 3 months ($297 total) initially. This gives you:

• One full month to establish baseline patterns
• One month to test interventions (meal order, post-meal walking, sleep optimisation)
• One month to confirm that improvements are sustained

After 90 days, most people have identified their key metabolic triggers and built habits to address them. At that point, you can either continue quarterly (one month on, two months off) or pause and revisit if habits slip.

Highest value users:

• Anyone with family history of type 2 diabetes
• People with HbA1c above 5.4% ("high normal")
• Those optimising body composition
• Performance athletes wanting carbohydrate periodisation guidance

---

Dexcom Stelo vs. Abbott Libre Sense#

The main competitor is the Abbott Libre Sense (also OTC in some markets). Key differences:

| Feature | Dexcom Stelo | Abbott Libre Sense | |---------|-------------|-------------------| | Accuracy (MARD) | 7.8% | 8.9% | | Sensor life | 15 days | 14 days | | App quality | ★★★★★ | ★★★☆☆ | | Real-time alerts | Limited | None | | Prescription | Not required | Not required | | Price | $99/mo | $89/mo |

Dexcom's accuracy edge and superior app make it the better choice despite the small price premium.

---

Final Verdict#

The Dexcom Stelo is the most important new health tracking tool available to non-diabetics. The glucose data it provides is not available from any other wearable — it makes the abstract concepts of metabolic health concrete, personal, and actionable.

In 42 days, it changed my sleep habits, meal composition, eating order, and post-meal behaviour. All four changes are supported by robust longevity science. CGM made me do them.

Score: 88/100. The $99/month cost prevents a higher score. If it were $49/month, it would be the most important wearable purchase you could make.

Dr. Sarah Chen wore three consecutive Dexcom Stelo sensors over 42 days. Device purchased independently. LongevityLab earns a commission on affiliate sales.